Page results
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
-
Patient Partners are patients, carers, families and people with lived experience of a specific issue or service. UCLH is committed to involving patients, carers, and members of the public in planning, developing, delivering, and monitoring the services we provide. Involving patients and the public in decision-making is crucial to ensuring that those services are what patients want and need.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page explains what FACETS is and how it can help you.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
File results
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0782 - Digital dictation, voice recognition software and outsourced transcription services
-
FOI/2022/0783 - Separate units/ beds allocated for delivery of CAR-T therapy and BMT services
-
FOI/2022/0785 - Patient treatment with Nivolumab
-
FOI/2022/0786 - A&E attendances for dog attacks - 2017-2022
-
FOI/2022/0790 - Eating disorder service for adults and adolescent /child
-
FOI/2022/0791 - Software used for cleanliness/ estates audits, high impact interventions and surgical site surveillance
-
FOI/2022/0793 - Post Covid-19 assessment service and related data collection
-
FOI/2022/0794 - Communication personnel and communication spend
-
FOI/2022/0795 - Mobile software (communications, chat, photo) used by the Trust